Clinical trial Recruiting at 1 site Interventional Ages 25 to 55

Investigating the role of small extracellular vesicles in insulin action related to obesity

Official title: Effect of Small Extracellular Vesicles From Adipose Tissue on Insulin Action

Run by Washington University School of Medicine · NCT05933707 · Data updated 2026-11-12

This study is testing how tiny particles in the blood from people with obesity might affect insulin action to see why some people stay healthy despite being overweight.

More Obesity trials

Quick facts

Study typeInterventional
Ages25 Years to 55 Years
SexAll
Enrollment72 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedJune 14, 2023
Main results expectedJune 1, 2028
Study endsAugust 31, 2028
Registry record updatedJuly 17, 2026
Trial IDNCT05933707 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with metabolically healthy obesity, metabolically unhealthy obesity, or metabolically healthy lean individuals.

Probably not a fit

Patients with a history of diabetes or serious liver diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to understand the differences in metabolic health among individuals with obesity, focusing on those who are metabolically healthy versus those who are not. The study will isolate small extracellular vesicles (sEVs) from participants' blood and adipose tissue to assess their effects on insulin sensitivity in cultured cells and in mice. By examining the bioactive molecules carried by these vesicles, the researchers hope to uncover mechanisms that protect some individuals from obesity-related metabolic diseases. The findings could provide insights into potential therapeutic targets for improving insulin action in those with obesity.

Why it matters

Potential benefit: If successful, this study could lead to new strategies for preventing or treating insulin resistance and related metabolic diseases in obese patients.

How similar studies have gone: While the specific approach of using sEVs in this context is novel, related studies have shown promise in understanding metabolic health and insulin resistance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Metabolically healthy lean subjects must have a BMI ≥18.5 and ≤24.9 kg/m²; Subjects with obesity must have a BMI ≥30.0 and ≤50.0 kg/m²
* Metabolically healthy lean and people with metabolically healthy obesity must have intrahepatic triglyceride (IHTG) content ≤5%; fasting plasma glucose concentration \<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration \<140 mg/dl, hemoglobin A 1C (HbA1c) ≤5.6% and HOMA-IR \<2.5.
* People with metabolically unhealthy obesity must have intrahepatic triglyceride (IHTG) content ≥5.6%; HOMA-IR ≥2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucose concentration ≥100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucose concentration ≥140 mg/dl.

Exclusion Criteria:

* History of diabetes, liver disease other than NAFLD or other serious diseases,
* Consume excessive amounts of alcohol (\>21 units/week for men and \>14 units/week for women),
* Take medications that could affect the study outcome measures, engage in regular exercise (\>120 min/week),
* Are pregnant or lactating

Where it's running

  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Lowering insulin to reduce liver fat production

    This study will try a short course of diazoxide to lower insulin and see if it reduces the liver's creation of new fat in adults with obesity, insulin resistance, and MASLD.

    Recruiting Phase 1 Columbia University · New York, New York · NCT07403604

  • Electro-acupuncture for adults with obesity and insulin resistance

    This study will test whether electro-acupuncture can improve insulin resistance in adults with obesity.

    Recruiting Nanyang Technological University · Singapore · NCT06609200

  • Investigating mitochondrial dysfunction in women with PCOS and infertility

    This study is trying to see if problems with energy production in cells are linked to polycystic ovary syndrome (PCOS) and infertility in women.

    Recruiting Semmelweis University · Budapest · NCT06167135

  • Endoscopic sleeve gastroplasty for people with obesity and MASH

    This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.

    Recruiting at 2 sites Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT06138821

  • Impact of weight loss on fat tissue signaling in muscles

    This study is testing how losing weight affects fat tissue in muscles and whether it helps people with obesity improve their insulin sensitivity.

    Recruiting University of Colorado, Denver · Aurora, Colorado · NCT06129110

  • Timed-Restricted Eating for Improving Metabolic Health

    This study is testing whether changing when people with obesity and insulin resistance eat can improve their metabolic health, liver fat, brain function, inflammation, and sleep quality.

    Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT06061042

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.